Boosting Immunity in Recipients of Live-Attenuated Zoster Vaccine
- PMID: 26452396
- PMCID: PMC9169853
- DOI: 10.1093/infdis/jiv481
Boosting Immunity in Recipients of Live-Attenuated Zoster Vaccine
Conflict of interest statement
Comment on
-
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.J Infect Dis. 2016 Jan 1;213(1):14-22. doi: 10.1093/infdis/jiv480. Epub 2015 Oct 9. J Infect Dis. 2016. PMID: 26452397 Clinical Trial.
References
-
- CDC. Prevention of herpes zoster. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid Mortal Wkly Rep Rec Rep 2008; 57(RR-5):1–31. - PubMed
-
- Oxman M, Levin M, Johnson G, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352:2271–84. - PubMed